Novel Technologies for in vivo Imaging (SBIR/STTR)
NCI and other NIH institutes invite applications for the development and delivery of novel image acquisition or enhancement technology and methods for biomedical imaging and image-guided interventions and therapy. NCI is focused on imaging in vivo for cancer pre-conditions and cancer screening, diagnosis, progression, treatment monitoring, recurrence, and surrogate endpoints. The focus includes the discovery, development, and delivery of cancer-specific imaging technologies, and optimization and validation of imaging technologies for cancer applications. This PA replaces PAR-03-125.
This PA will use the SBIR/STTR award mechanism.
Novel Technologies for in vivo Imaging (R21/R33)
NCI invites applications for the development and delivery of novel image acquisition or enhancement technologies and methods for biomedical imaging and image-guided interventions and therapy that may incorporate limited pilot or clinical feasibility evaluations using either pre-clinical models or clinical studies. This initiative is primarily intended to facilitate technologies for early detection, screening, diagnosis, image-guided interventions, and treatment of various diseases. This PA replaces PAR-03-124.
This PA will use the NIH R33 Exploratory Developmental Phase II Award and the combined R21/R33 Phased-Innovation Award mechanisms. For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2021.
Additional Genotyping for the Human Haplotype Map
This RFA solicits applications for a cooperative agreement to augment the International HapMap Project by supporting the genotyping of approximately 2.25 million SNPs across the genome in 270 samples from 4 populations, at high quality and at a cost of about 1 cent per genotype. The data from this effort will contribute to the development of a map, called the HapMap, of the haplotype patterns in the human genome and of a set of SNPs that are informative about these patterns and the associations among the SNPs.
This RFA will use the NIH U54 Specialized Center Cooperative Agreement award mechanism. For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2023.
Inquiries: Dr. Wendy Wang, email@example.com